Life after tuberculosis: planning for health.,The Lancet Respiratory Medicine

当前位置： X-MOL 学术 › Lancet Respir. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Life after tuberculosis: planning for health.
The Lancet Respiratory Medicine ( IF 38.7 ) Pub Date : 2019-10-29 , DOI: 10.1016/s2213-2600(19)30371-6
C Andrew Basham ₁ , Kamila Romanowski ₂ , James C Johnston ₃

Affiliation

WHO developed the End TB Strategy as a blueprint and call to action for governments worldwide to work towards tuberculosis elimination. The strategy's goal to reduce mortality from tuberculosis by 95% from 2015 to 2035 has major implications for health policy and planning. Globally, millions of people survive after tuberculosis treatment each year. From 2000 to 2018, WHO estimates that 58 million deaths were averted by interventions for tuberculosis among HIV-negative people and interventions for both tuberculosis and HIV among HIV-positive people. Many more people are expected to survive tuberculosis in the years to come, and this growing population of survivors might be living with chronic conditions associated with, caused by, or exacerbated by tuberculosis long after completing treatment.

中文翻译：

结核病后的生活：为健康做计划。

世卫组织制定了《结核病最终防治战略》作为蓝图，并呼吁全球各国政府为消除结核病而努力。该战略的目标是从2015年到2035年将结核病死亡率降低95％，这对卫生政策和规划产生了重大影响。全球每年有数百万人在接受结核病治疗后得以生存。从2000年至2018年，世卫组织估计，艾滋病毒阴性人群中的结核病干预措施和艾滋病毒呈阳性人群中的结核病和HIV干预措施避免了5800万人的死亡。预计未来几年还会有更多的人幸存下来，而且越来越多的幸存者可能会在完成治疗后很长一段时间内患有与结核有关，由结核引起或加重的慢性疾病。

更新日期：2019-11-26

点击分享查看原文

点击收藏

阅读更多本刊最新论文